IL-17受体C信号调控CD4+ TH17免疫反应及免疫介导性肾病组织损伤
研究在肾毒性肾炎、银屑病和结肠炎模型中,通过单细胞RNA测序及TH17细胞特异性IL-17RA/IL-17RC基因缺陷小鼠,发现CD4+ TH17细胞表达IL-17受体A/C复合物,破坏IL-17RC信号通路可增强IL-17细胞因子反应并加速实验性新月体性肾小球肾炎病程。
要点
- CD4+ TH17细胞特异性表达IL-17受体A/C复合物
- TH17细胞中IL-17RC信号通路破坏增强IL-17反应并加速新月体性肾小球肾炎
- 银屑病和结肠炎模型观察到类似结果
核心结论
- IL-17受体C信号在调控CD4+ TH17细胞及控制器官特异性自身免疫中具有此前未被认识的功能,可能为开发更有效的抗TH17治疗策略提供新见解。
研究设计与样本
- 在IL-17A、IFNγ和Foxp3三报告基因小鼠中诱导新月体性肾小球肾炎(肾毒性肾炎),分选肾脏CD4+ T细胞亚群并进行单细胞RNA测序。
- 构建TH17细胞特异性IL-17RA和IL-17RC基因缺陷小鼠,研究IL-17信号在TH17细胞中的功能作用,模型包括新月体性肾小球肾炎、咪喹莫特诱导的银屑病和CD4+CD45RBhigh T细胞转移结肠炎模型。
主要发现
- 鉴定出CD4+ TH17细胞上IL-17受体A/C复合物的特异性表达。
- TH17细胞的单细胞RNA测序显示实验性新月体性肾小球肾炎中IL-17受体信号通路激活。
- 在CD4+ T细胞中、尤其是CD4+ TH17细胞中特异性破坏IL-17RC信号通路,增强IL-17细胞因子反应并导致实验性新月体性肾小球肾炎病程加速。
- 在实验性银屑病和结肠炎模型中观察到类似结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: IL-17A-producing CD4+ T helper (TH17) cells play a critical role in autoimmune and chronic inflammatory diseases, such as crescentic GN. The proinflammatory effects of IL-17 are mediated by the activation of the IL-17RA/IL-17RC complex. Although the expression of these receptors on epithelial and endothelial cells is well characterized, the IL-17 receptor expression pattern and function on hematopoietic cells, e.g., CD4+ T cell subsets, remains to be elucidated. METHODS: Crescentic GN (nephrotoxic nephritis) was induced in IL-17A, IFNγ, and Foxp3 triple-reporter mice for sorting of renal CD4+ T cell subsets and subsequent single-cell RNA sequencing. Moreover, we generated TH17 cell-specific IL-17RA and IL-17RC gene-deficient mice and studied the functional role of IL-17 signaling in TH17 cells in crescentic GN, imiquimod-induced psoriasis, and in the CD4+CD45RBhigh T cell transfer colitis model. RESULTS: We identified a specific expression of the IL-17 receptor A/C complex on CD4+ TH17 cells. Single-cell RNA sequencing of TH17 cells revealed the activation of the IL-17 receptor signaling pathway in experimental crescentic GN. Disruption of the IL-17RC signaling pathway in CD4+ T cells and, most importantly, specifically in CD4+ TH17 cells, potentiates the IL-17 cytokine response and results in an accelerated course of experimental crescentic GN. Comparable results were observed in experimental models of psoriasis and colitis. CONCLUSIONS: Our findings indicate that IL-17 receptor C signaling has a previously unrecognized function in the regulation of CD4+ TH17 cells and in the control of organ-specific autoimmunity and might provide new insights into the development of more efficient anti-TH17 treatment strategies.
引用
- Schmidt T, Luebbe J, Kilian C, et al. IL-17 Receptor C Signaling Controls CD4+ TH17 Immune Responses and Tissue Injury in Immune-Mediated Kidney Diseases. J Am Soc Nephrol. 2021. PMID: 35167487. doi:10.1681/ASN.2021030426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。